Skip to main content
. Author manuscript; available in PMC: 2010 Jun 2.
Published in final edited form as: Curr Opin HIV AIDS. 2009 May;4(3):176–182. doi: 10.1097/COH.0b013e328329c62f

Figure 1.

Figure 1

Multiple factors contribute to CVD risk among patients with HIV infection, including traditional risk factors as well as mechanisms related to viral replication and ART. While ART use may decrease HIV-mediated CVD risk via suppression of viral replication, it is also associated with drug toxicity that itself is known to confer CVD risk. There may also be other HIV- and ART-specific CVD risk factors not discussed here (dotted lines). Thus, the net influence of ART on CVD risk, in the setting of HIV infection, remains to be defined.